Skip to main content
. 2020 Aug 5;9(16):e017015. doi: 10.1161/JAHA.120.017015

Table 2.

Association Between Time‐Averaged On‐Treatment Blood Pressure and Incident Diabetes Mellitus

BP, mm Hg n No. of Events (%) Crude Model Adjusted Model*
OR (95% CI) P Value OR (95% CI) P Value
Time‐averaged on‐treatment SBP
<120 263 23 (8.7) 1.20 (0.76‒1.88) 0.435 1.25 (0.78‒1.99) 0.358
120 to <130 2658 197 (7.4) Ref. Ref.
130 to <140 5878 606 (10.3) 1.44 (1.21‒1.70) <0.001 1.37 (1.15‒1.64) <0.001
≥140 6179 802 (13.0) 1.86 (1.58‒2.19) <0.001 1.67 (1.39‒2.00) <0.001
Time‐averaged on‐treatment DBP
<70 491 42 (8.6) 0.80 (0.57‒1.11) 0.172 0.76 (0.53‒1.07) 0.117
70 to <80 4788 504 (10.5) Ref. Ref.
80 to <90 7434 814 (10.9) 1.05 (0.93‒1.18) 0.461 1.13 (0.98‒1.30) 0.090
≥90 2265 268 (11.8) 1.14 (0.97‒1.34) 0.101 1.30 (1.06‒1.61) 0.012
P for trend 0.031 0.003
Time‐averaged on‐treatment SBP/DBP
<130 and <80 1603 125 (7.8) Ref. Ref.
130 to <140 and/or 80 to <90 6618 651 (9.8) 1.29 (1.06‒1.58) 0.012 1.24 (1.00‒1.53) 0.047
≥140 and/or ≥90 6757 852 (12.6) 1.71 (1.40‒2.08) <0.001 1.54 (1.24‒1.92) <0.001

BP indicates blood pressure; DBP, diastolic blood pressure; OR, odds ratio; and SBP, systolic blood pressure.

*

Adjusted for age, sex, study center, body mass index, smoking, family history of diabetes mellitus, systolic blood pressure, diastolic blood pressure, fasting glucose, total cholesterol, triglycerides, creatinine, folate, and the use of antihypertensive drugs at baseline, as well as use of calcium channel blockers or diuretics during the treatment period.